Literatur
Rau R, Herborn G (2004) Benefit and risk of methotrexate treatment in rheumatoid arthritis. Clin Exp Rheumatol (Suppl 35) 22: S83–S94
Cronstein BN (2005) Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev 57: 163–172
Hamilton RA, Kremer JM (1997) Why intramuscular methotrexate may be more efficacious than oral dosing in patients with rheumatoid arthritis. Br J Rheumatol 36: 86–90
Hoekstra M, Haagsma C, Neef C et al. (2004) Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis. J Rheumatol 31: 645–648
Wegrzyn J, Adeleine P, Miossec P (2004) Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis. Ann Rheum Dis 63: 1232–1234
Rozin A, Schapira D, Balbir-Gurman A et al. (2002) Relapse of rheumatoid arthritis after substitution of oral for parenteral administration of methotrexate. Ann Rheum Dis 61: 756–757
Bingham SJ, Buch MH, Lindsay S et al. (2003) Parenteral methotrexate should be given before biological therapy. Rheumatology 42: 1009–1010
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krüger, K. Methotrexat. Z. Rheumatol. 67, 332–333 (2008). https://doi.org/10.1007/s00393-008-0295-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00393-008-0295-4